A flavonoid gossypin binds to cyclin-dependent kinase 2
Hojung Kim1, Eunjung Lee, Jihye Kim
1Department of Bioscience and Biotechnology, BMIC, 1 Hwayang-dong, Kwangjin-Ku, Konkuk University, Seoul 143-701, Republic of Korea.
Bioorganic & Medicinal Chemistry Letters
|December 8, 2007
Summary
Researchers screened 347 flavonoid derivatives for binding to cyclin-dependent kinase 2 (CDK2). Gossypin showed promising CDK2 binding effects, confirmed by NMR experiments.
Area of Science:
- Biochemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Flavonoids are natural compounds known for low toxicity and mild biological activity.
- Cyclin-dependent kinase 2 (CDK2) is a key regulator of the cell cycle, making it a target for therapeutic intervention.
Purpose of the Study:
- To identify novel flavonoid derivatives with potential CDK2 binding capabilities.
- To investigate the molecular interactions between flavonoids and CDK2.
Main Methods:
- Computational docking of 347 flavonoid derivatives against the CDK2 crystal structure.
- Experimental validation of binding affinity using Nuclear Magnetic Resonance (NMR) spectroscopy.
Main Results:
- The docking study identified gossypin as a flavonoid derivative with a favorable conformational fit within the CDK2 binding site.
- NMR binding assays confirmed the interaction between gossypin and CDK2, supporting its potential as a CDK2 inhibitor.
Conclusions:
- Gossypin exhibits significant binding affinity to CDK2, suggesting its potential as a lead compound for developing new therapeutics targeting CDK2.
- This study highlights the utility of integrating computational docking with experimental validation for discovering bioactive natural compounds.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.